These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 23216833)
1. The superhealing MRL background improves muscular dystrophy. Heydemann A; Swaggart KA; Kim GH; Holley-Cuthrell J; Hadhazy M; McNally EM Skelet Muscle; 2012 Dec; 2(1):26. PubMed ID: 23216833 [TBL] [Abstract][Full Text] [Related]
2. Cardiac function in muscular dystrophy associates with abdominal muscle pathology. Gardner BB; Swaggart KA; Kim G; Watson S; McNally EM J Neuromuscul Dis; 2015; 2(1):39-49. PubMed ID: 26029630 [TBL] [Abstract][Full Text] [Related]
3. Distinct genetic regions modify specific muscle groups in muscular dystrophy. Swaggart KA; Heydemann A; Palmer AA; McNally EM Physiol Genomics; 2011 Jan; 43(1):24-31. PubMed ID: 20959497 [TBL] [Abstract][Full Text] [Related]
4. The super-healing MRL strain promotes muscle growth in muscular dystrophy through a regenerative extracellular matrix. O'Brien JG; Willis AB; Long AM; Kwon J; Lee G; Li FW; Page PG; Vo AH; Hadhazy M; Spencer MJ; Crosbie RH; Demonbreun AR; McNally EM JCI Insight; 2024 Jan; 9(3):. PubMed ID: 38175727 [TBL] [Abstract][Full Text] [Related]
5. Modifiers of heart and muscle function: where genetics meets physiology. Swaggart KA; McNally EM Exp Physiol; 2014 Apr; 99(4):621-6. PubMed ID: 24213858 [TBL] [Abstract][Full Text] [Related]
6. The super-healing MRL strain promotes muscle growth in muscular dystrophy through a regenerative extracellular matrix. O'Brien JG; Willis AB; Long AM; Kwon J; Lee G; Li F; Page PGT; Vo AH; Hadhazy M; Crosbie RH; Demonbreun AR; McNally EM bioRxiv; 2023 Jun; ():. PubMed ID: 37425960 [TBL] [Abstract][Full Text] [Related]
7. Biochemical and Functional Comparisons of mdx and Sgcg(-/-) Muscular Dystrophy Mouse Models. Roberts NW; Holley-Cuthrell J; Gonzalez-Vega M; Mull AJ; Heydemann A Biomed Res Int; 2015; 2015():131436. PubMed ID: 26064876 [TBL] [Abstract][Full Text] [Related]
8. Systemic γ-sarcoglycan AAV gene transfer results in dose-dependent correction of muscle deficits in the LGMD 2C/R5 mouse model. Seo YE; Baine SH; Kempton AN; Rogers OC; Lewis S; Adegboye K; Haile A; Griffin DA; Peterson EL; Pozsgai ER; Potter RA; Rodino-Klapac LR Mol Ther Methods Clin Dev; 2023 Mar; 28():284-299. PubMed ID: 36816759 [TBL] [Abstract][Full Text] [Related]
9. Extraocular muscle is spared despite the absence of an intact sarcoglycan complex in gamma- or delta-sarcoglycan-deficient mice. Porter JD; Merriam AP; Hack AA; Andrade FH; McNally EM Neuromuscul Disord; 2001 Mar; 11(2):197-207. PubMed ID: 11257478 [TBL] [Abstract][Full Text] [Related]
10. Sexually dimorphic skeletal muscle and cardiac dysfunction in a mouse model of limb girdle muscular dystrophy 2i. Maricelli JW; Kagel DR; Bishaw YM; Nelson OL; Lin DC; Rodgers BD J Appl Physiol (1985); 2017 Nov; 123(5):1126-1138. PubMed ID: 28663375 [TBL] [Abstract][Full Text] [Related]
11. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse. Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230 [TBL] [Abstract][Full Text] [Related]
12. Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2). Duggan DJ; Manchester D; Stears KP; Mathews DJ; Hart C; Hoffman EP Neurogenetics; 1997 May; 1(1):49-58. PubMed ID: 10735275 [TBL] [Abstract][Full Text] [Related]